ArticleFrontiers in oncology2022

DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer.

Mingyue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.